高血糖与手术并发症的悖论关联:糖尿病患者与非糖尿病患者对比
这项回顾性队列研究纳入7634例普外、血管及妇科手术患者,发现术后24小时内血糖≥140 mg/dL时,无糖尿病患者的并发症风险高于糖尿病患者,且在血糖180-249 mg/dL和>250 mg/dL时 adjusted OR 分别为1.49和1.88;胰岛素治疗可能减轻该关联。
要点
- 术后高血糖时无糖尿病患者的并发症风险高于糖尿病患者。
- 血糖180-249 mg/dL时无糖尿病者并发症 adjusted OR 1.49。
- 胰岛素治疗可能减轻无糖尿病患者的这一风险。
核心结论
- 在近乎普遍血糖检测和频繁胰岛素使用下,无糖尿病患者在相似高血糖水平时结局 paradoxically 差于糖尿病患者,胰岛素可能减轻该效应。
主要发现
- 高血糖(术后24小时内血糖≥140 mg/dL)发生在882例糖尿病患者(91%)和2484例无糖尿病患者(50.7%)。
- 血糖140-179 mg/dL时,无糖尿病 vs 糖尿病并发症 adjusted OR 1.83(95% CI 0.93-3.6)。
- 血糖180-249 mg/dL时 adjusted OR 1.49(95% CI 1.06-2.11)。
- 血糖>250 mg/dL时 adjusted OR 1.88(95% CI 1.11-3.17)。
- 严重并发症呈现相似趋势;血糖>180 mg/dL者中1388例(72.7%)接受胰岛素。
关键数值与推荐
- 高血糖定义为术后24小时内血糖≥140 mg/dL。
- 血糖>180 mg/dL者中72.7%接受胰岛素,其中糖尿病高血糖患者91%、无糖尿病高血糖患者61%。
临床怎么用
- 术后应常规监测血糖,对无糖尿病患者出现高血糖时也应积极考虑胰岛素治疗以降低并发症风险。
局限性
- 单中心回顾性设计,仅纳入预计住院至少48小时的患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Surgical complications associated with perioperative hyperglycemia are conventionally associated with diabetes, but, paradoxically, prior cohort studies have found that patients without diabetes have greater risk of complications at similar levels of hyperglycemia compared with patients with diabetes. OBJECTIVE: To describe the association between perioperative hyperglycemia and surgical complications in a population of surgical patients without diabetes receiving routine blood glucose testing and insulin administration and to evaluate the potential correlation of perioperative hyperglycemia. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study of National Surgical Quality Improvement Program-defined complications after operation took place at a single academic medical center hospital from January 2013 to October 2016. Consecutive patients undergoing general, vascular, and gynecologic operations who were expected to have at least a 48-hour admission were included. Hyperglycemia was defined as blood glucose level of 140 mg/dL or higher within 24 hours after surgery. Multivariate regression was used to assess the association of hyperglycemia and complications, stratified by hyperglycemia severity and adjusted for diabetes status. Analysis began in February 2022. EXPOSURES: Routine blood glucose testing and insulin administration. MAIN OUTCOMES AND MEASURES: The main outcomes are odds of experiencing perioperative hyperglycemia and postoperative complication, comparing patients with and without diabetes. RESULTS: A total of 7634 patients (mean [SD] age, 53.5 [15.1] years; 6664 patients without diabetes [83.3%] and 970 patients with diabetes [17.7%]) underwent general (6204 [81.3%]), vascular (208 [2.7%]), and gynecologic (1222 [16%]) operations. Of these, 5868 (77%) had blood glucose testing (4899 individuals without diabetes [73.5%] and 969 [99.9%] with diabetes). Hyperglycemia occurred in 882 patients with diabetes (91%) and 2484 patients without diabetes (50.7%). Of those with blood glucose level more than 180 mg/dL, 1388 (72.7%) received insulin (658 patients with diabetes who had hyperglycemia [91%] and 680 patients without diabetes who had hyperglycemia [61%]). Adjusted odds of experiencing a complication were 83% greater for patients without vs with diabetes at blood glucose level of 140 to 179 mg/dL (odds ratio, 1.83 [95% CI, 0.93-3.6]), 49% greater for blood glucose level of 180 to 249 mg/dL (odds ratio, 1.49 [95% CI, 1.06-2.11]), and 88% greater for blood glucose level more than 250 mg/dL (odds ratio, 1.88 [95% CI, 1.11-3.17]). A similar trend was observed for serious complications. Insulin may mitigate the association of hyperglycemia and complications in patients without diabetes. CONCLUSIONS AND RELEVANCE: In this study, with near universal blood glucose testing and frequent insulin use, patients without diabetes paradoxically had worse outcomes than patients with diabetes at similar levels of hyperglycemia. Insulin may mitigate this effect and broader use may improve outcomes.
引用
- Chen JY, Nassereldine H, Cook SB, et al. Paradoxical Association of Hyperglycemia and Surgical Complications Among Patients With and Without Diabetes. JAMA Surg. 2022. PMID: 35704308. doi:10.1001/jamasurg.2021.5561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。